Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Esophageal Neoplasms × Rocuronium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Prolapse 1 Renal Insufficiency, Chronic 1 Prostatic Neoplasms 1 Neuromuscular Blockade 1 Leiomyoma 1 Intestinal Obstruction 1 Esophageal Neoplasms 1 Endometriosis 1 Endobronchial Metastases 1 Cholecystitis 1

Interventions

sodium glycididazole 4 iron isomaltoside 1000 1 apatinib 1 Tranexamic Acid 1 Tobacco Use Cessation Devices 1 Rocuronium 1 Psychiatric Rehabilitation 1 Pravastatin 1 Polymerase Chain Reaction 1 Photochemotherapy 1 Pafolacianine 1 Paclitaxel 1 Oxaliplatin 1 Immunonutrition Diet 1 Heparin, Low-Molecular-Weight 1 Gene Expression Profiling 1 Fluorouracil 1 Epinephrine 1 Enteral Nutrition 1 Ensure Plus 1 Early Intervention, Educational 1 Counseling 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02320734 2016-09-19

DEPTH

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 4 Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡